Ardelyx (ARDX) Long-Term Investments (2020)

Ardelyx (ARDX) reported Long-Term Investments of $2.1 million for Q4 2020.

Ardelyx (ARDX) Long-Term Investments (2020) Analysis & Trends

Ardelyx has reported Long-Term Investments for 1 years, with the latest figure at $2.1 million in Q4 2020.

For the quarter ending Q4 2020, Long-Term Investments changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2020 stood at $2.1 million (changed N/A YoY), and the FY2020 full-year result was $2.1 million, changed N/A from the prior year.
Long-Term Investments for Q4 2020 stood at $2.1 million.
The five-year high for Long-Term Investments was $2.1 million in Q4 2020, with the low at $2.1 million in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	5.17 Mn
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	5.75 Bn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Ardelyx	1.49 Bn	1.25 Bn	89.66 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	2.11 Mn